Abstract The aim of the study was to compare device life of more recent indwelling voice prostheses Provox Vega and Blom-Singer Dual Valve to device life of well-known standard devices (Provox 2, Blom-Singer Classic). In a prospective, non-randomised study, device life of Blom-Singer Classic, Blom-Singer Dual Valve, Provox2, Provox Vega and Provox ActiValve voice prostheses was recorded in a group of 102 laryngectomised patients. In total 749 voice prosthesis were included. Average overall life time was 108 days, median 74 days. The prosthesis with the longest dwell time was the Provox ActiValve (median 291 days). Provox Vega had longer device life compared with Provox2 (median 92 days vs 66 days; p = 0.006) and compared with Blom-Singer Cl...
Annually, approximately 600 patients are laryngectomized due to laryngeal cancer in The Netherlands....
A study was undertaken to determine whether the Provox® voice prosthesis provides good voice rehabil...
Aim: To obtain information about valved speech and related issues in patients who have undergone to...
The Provox® (Atos Medical AB, Hörby, Sweden) voice prosthesis was developed between 1988 and 1990 an...
Objectives: To assess the long-term results of the Provox ActiValve, a prosthesis for voice rehabili...
voice prosthesis is as yet untested outside Europe. The current study examined device life and reaso...
Device life of the Provox Vega Indwelling voice prosthesis is as yet untested outside Europe. The cu...
To prospectively study patients' preference for and the lifetime of the Groningen Ultra Low Resistan...
To prospectively study patients' preference for and the lifetime of the Groningen Ultra Low Resistan...
Conclusions: Provox Vega prostheses demonstrate good short-term feasibility, and their optimized air...
Conclusion. The new Provox(R) NID (TM) non- indwelling voice prosthesis investigated in this study p...
Objective: To assess long term results with use of indwelling voice prosthesis (Provox) for vocal re...
Background: Technical and device life issues are frequently the focus of post-laryngectomy rehabilit...
Objective: Voice prosthesis leakage significantly affects the quality of life of patients undergoing...
Objective To investigate the difference between voice prostheses in terms of voice quality as experi...
Annually, approximately 600 patients are laryngectomized due to laryngeal cancer in The Netherlands....
A study was undertaken to determine whether the Provox® voice prosthesis provides good voice rehabil...
Aim: To obtain information about valved speech and related issues in patients who have undergone to...
The Provox® (Atos Medical AB, Hörby, Sweden) voice prosthesis was developed between 1988 and 1990 an...
Objectives: To assess the long-term results of the Provox ActiValve, a prosthesis for voice rehabili...
voice prosthesis is as yet untested outside Europe. The current study examined device life and reaso...
Device life of the Provox Vega Indwelling voice prosthesis is as yet untested outside Europe. The cu...
To prospectively study patients' preference for and the lifetime of the Groningen Ultra Low Resistan...
To prospectively study patients' preference for and the lifetime of the Groningen Ultra Low Resistan...
Conclusions: Provox Vega prostheses demonstrate good short-term feasibility, and their optimized air...
Conclusion. The new Provox(R) NID (TM) non- indwelling voice prosthesis investigated in this study p...
Objective: To assess long term results with use of indwelling voice prosthesis (Provox) for vocal re...
Background: Technical and device life issues are frequently the focus of post-laryngectomy rehabilit...
Objective: Voice prosthesis leakage significantly affects the quality of life of patients undergoing...
Objective To investigate the difference between voice prostheses in terms of voice quality as experi...
Annually, approximately 600 patients are laryngectomized due to laryngeal cancer in The Netherlands....
A study was undertaken to determine whether the Provox® voice prosthesis provides good voice rehabil...
Aim: To obtain information about valved speech and related issues in patients who have undergone to...